2022 Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2022 The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities Group Cellular Therapy & Immunobiology Working Party (CTIWP) Nursing Research Committee Nursing Scientific Committee 1st listed author Rose Ellard Journal Clin Hematol Int.
2022 Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Hemasphere.
2022 Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Nicole Santoro Journal Bone Marrow Transplant.
2022 Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper Group Chronic Malignancies Working Party (CMWP) Cellular Therapy & Immunobiology Working Party (CTIWP) Lymphoma Working Party (LWP) Patient Advocacy Committee Trainee Committee Nursing Research Committee Nursing Scientific Committee 1st listed author Nico Gagelmann Journal Lancet Haematol.
2022 Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP) Group Acute Leukemia Working Party (ALWP) 1st listed author Eleni Gavriilaki Journal Bone Marrow Transplant.
2022 Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2022 Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Alexandros Spyridonidis Journal Bone Marrow Transplant.
2022 Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modelling Group Chronic Malignancies Working Party (CMWP) 1st listed author Sarah Lawless Journal Haematologica.
2022 STEM CELL TRANSPLANTATION IN PATIENTS AFFECTED BY SHWACHMAN- DIAMOND SYNDROME: EXPERT CONSENSUS AND RECOMMENDATIONS FROM THE EBMT SEVERE APLASTIC ANAEMIA WORKING PARTY Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Simone Cesaro Journal Transplant Cell Ther.
2022 Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT) Group Acute Leukemia Working Party (ALWP) 1st listed author Enrico Maffini Journal Bone Marrow Transplant.
2022 The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency Group Inborn Errors Working Party (IEWP) 1st listed author Jerold Jeyaratnam Journal Pediatr Rheumatol Online J.